Tirzepatide 50mg/3mL is a high-potency dual-incretin peptide solution studied for its activity at both GIP and GLP-1 receptors. Researchers continue to explore its involvement in metabolic regulation, glucose utilization, appetite control, and energy management pathways. Its innovative dual-receptor mechanism has positioned Tirzepatide as one of the most actively researched peptides in the metabolic science field.
Lot-traced · COA on file · Sterility & mycoplasma tested
PEPTIDE DOSE: Select dose
DRAW SYRINGE TO: Select values
YOUR VIAL CONTAINS: Select values
CONCENTRATION: Select values
Tirzepatide’s dual-pathway activity provides researchers with a unique opportunity to investigate interconnected metabolic processes. Through engagement with both GIP and GLP-1 receptors, studies examine how these pathways influence nutrient metabolism, hormonal signaling, and overall metabolic efficiency.
Apply once, get reviewed by our team, and access provider-only pricing across peptides, exosomes, and cellular products.
PRODUCT USAGE: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product is intended strictly for laboratory research and qualifies under appropriate regulatory frameworks for research-only use. It is not intended to diagnose, treat, cure, or prevent any disease or condition. This product should only be handled by licensed, qualified professionals. It is not intended for use by the general public. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
